PUBLISHER: DataM Intelligence | PRODUCT CODE: 1575748
PUBLISHER: DataM Intelligence | PRODUCT CODE: 1575748
Overview
Global Bilirubin Meters Market reached US$ 108.1 million in 2023 and is expected to reach US$ 136.4 million by 2031, growing at a CAGR of 10.16% during the forecast period 2024-2031.
The bilirubin meter is a device that measures the amount of bilirubin in a patient's blood. It is an important tool in the diagnosis and treatment of neonatal jaundice. It typically uses spectrophotometric methods to measure bilirubin levels, which aids in the diagnosis and monitoring of illnesses like jaundice, liver disease, and hemolytic disorders.
Bilirubin meters can be found in both portable and laboratory settings, giving essential data for clinical decision-making. Commonly used in neonates to assess jaundice, determining its severity and the need for treatment, such as phototherapy. They help in evaluating and analyzing bilirubin metabolism and help in diagnosing liver diseases such as hepatitis, cirrhosis, and other metabolic diseases.
Market Dynamics: Drivers & Restraints
Technological advancement in bilirubin meters
Technological advancements in bilirubin meters are expected to drive the market growth. Enhanced measuring techniques, such as enhanced spectrophotometry and multi-wavelength analysis, produce more consistent results, boosting trust in these instruments. Non-invasive bilirubin meters, that utilize light sensors to monitor bilirubin levels via the skin are expected to improve the comfort and accessibility of screening, especially for babies.
Advances in miniaturization and user interface design have led to more portable, simple-to-use devices that can be operated by healthcare professionals with minimal instruction, allowing for widespread use. Faster analysis times improve workflow efficiency in clinical environments, allowing for rapid diagnostic and treatment decisions. Technological advancements can result in lower manufacturing costs, making bilirubin meters cheaper for healthcare facilities and boosting market share. Thus, the above factors are expected to drive the market growth.
High cost of the devices
Hospitals and clinics, particularly in low- and middle-income areas, may need help with funding costly equipment. This can limit their ability to invest in new technologies, impeding their adoption. If cheaper options exist, buyers in the future may choose them, making it difficult for high-priced products to compete. This could result in a lower market share for premium products.
The global bilirubin meters market is segmented based on product type, age group, indication, end-user, and region.
Transcutaneous segment is expected to dominate the market share
The transcutaneous segment holds a significant position in the global market share and is expected to continue throughout the forecast period. These gadgets are non-invasive, accurate, cost-effective, and time-saving.
Moreover, transcutaneous devices are used to screen jaundice in newborn babies without a needle prick, and they are becoming more popular as an alternative to serum bilirubin analyzers. Transcutaneous bilirubinometers serve as a valid screening method for identifying neonates who require total serum bilirubin measurement before phototherapy.
Transcutaneous meters produce immediate results, allowing for more rapid clinical decision-making and rapid action in situations like as jaundice. Due to their efficiency and portability, these devices are gaining demand and are expected to hold a significant position in the market share.
North America is expected to hold a significant position in the bilirubin meters market share
North America accounted for the highest revenue share. The increasing prevalence of liver diseases, the rising geriatric population, rising healthcare spending, well-established infrastructure, and technological advancements in bilirubin meters are factors expected to boost the market in the forecast period.
For instance, according to the Children's Hospital of Philadelphia in 2024, it is stated that hyperbilirubinemia is very common, affecting approximately 60 percent of term newborns and 80 percent of premature babies develop jaundice. The increasing number of hyperbilirubinemias requires continuous evaluation and analysis of the quantity of bilirubin, thus increasing the demand for the devices. Thus, the above factors are expected to hold the region's market growth.
The major global players in the market include Delta Medical International Ltd, Mennen Medical Ltd, Ningbo David Medical Device Co. Ltd., Micro Lab Instruments, Zeal Medical, Dragerwerk AG & Co. KGaA, Labtron Equipment Ltd, Korrida Medical Systems, GPC Medical Ltd and Braun & Co. Limited. among others.
The global bilirubin meters market report would provide approximately 53 tables, 47 figures, and 176 pages.
LIST NOT EXHAUSTIVE